A Clinical Trial of Immuno-bridging Between Different Manufacture Scales of Recombinant COVID-19 Vaccine (Sf9 Cell)
Condition(s):COVID-19; SARS-CoV-2 PneumoniaLast Updated:July 20, 2022Unknown status
Hide Studies Not Open or Pending
Condition(s):COVID-19; SARS-CoV-2 PneumoniaLast Updated:July 20, 2022Unknown status
Condition(s):SARS-CoV InfectionLast Updated:April 12, 2022Recruiting
Condition(s):HIV; Organ Transplantation; Lymphoma, Non-Hodgkin; Chronic Lymphocytic Leukemia; Multiple Myeloma; COVID-19 VaccinesLast Updated:June 1, 2023Recruiting
Condition(s):Coronavirus 2019; Healthcare Workers; VaccineLast Updated:September 22, 2023Completed
Condition(s):Influenza Immunization; Healthy VolunteersLast Updated:October 3, 2023Completed
Condition(s):COVID-19; Vaccine-Preventable Diseases; SARS CoV 2 Infection; Upper Respiratory Tract Infection; Upper Respiratory DiseaseLast Updated:November 28, 2023Recruiting
Condition(s):COVID-19; Vaccine Hesitancy; Vaccination; NursesLast Updated:January 28, 2022Unknown status
Condition(s):COVID-19Last Updated:February 18, 2022Completed
Condition(s):IBD; Covid19 VaccineLast Updated:December 7, 2022Completed
Condition(s):Adverse Reaction to Vaccine; COVID19 VaccineLast Updated:April 6, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.